Answers are grounded in this paper and cite their sources.
Background: The radioiodine ablation (RIA) of thyroid residuum in patients with differentiated thyroid cancer (DTC) is an important stage of complex treatment. The aim of RIA is the elimination of potential foci of DTC and creating conditions for monitoring of the patients. Prognosis of the efficacy of RIA is important for further planning of the complex treatment. The aim of the study was to improve a prognosis of RIA of thyroid residual tissue (TRT) in patients with DTC using scintigraphic date about 131I kinetics, that reflect a radioresistance of a thyroid tissue. Material and Methods: The results of RIA of TRT in 62 patients were analyzed. During radioiodine therapy (RIT) the elimination halftime of 131I from TRT in time interval 3–6 days after administration of therapeutic activities was determined, and the focal radiation adsorbed doses (FRAD) in TRT were calculated. Results: It was determined that values Т1/2 ≥ 4.0 days may indicate on the high probability of the incomplete RIA of TRT at FRAD within 50–500 Gy, while values Т1/2 ≤ 1.9 days – on the radiosensitivity of the thyroid tissue and the great probability of the complete RIA. Conclusions: During RIT of DCT the elimination halftime of iodine-131, determined on time interval 3–6 days after the administration of therapeutic activities may be used as one of predicative indices of RIA efficacy. Since the elimination halftime of the radiopharmaceutical reflects the individual natural radiosensitivity of TRT, this approach may be applied in studies of the radioresistance of a normal human tissue.
No takes yet. Share an insight, caveat, or question.
Dzhuzha Da (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: